Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.5K
Overview
44.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Foot-and-Mouth Disease Virus Persistence Divergence Within Serotypes and Vaccine Doses in Vaccinated Cattle.

Transboundary and emerging diseases·2026
Same author

Chloroplast photorespiratory bypass in tomato couples carbon-nitrogen assimilation to increase yield and fruit quality.

Cell reports·2026
Same author

Boosted charge separation in CoWO<sub>4</sub>/SnIn<sub>4</sub>S<sub>8</sub> S-scheme heterojunctions toward high-performance photocatalytic carbon dioxide reduction and formaldehyde oxidation.

Journal of colloid and interface science·2026
Same author

rRNA intermediates associate with nucleolar reshaping in C. elegans.

Nucleic acids research·2026
Same author

A Dinucleating Modular Phosphine-Pyridine-Oxazoline Ligand for Cu-Catalyzed Asymmetric Dearomative Propargylic Substitutions.

Journal of the American Chemical Society·2026
Same author

Research Hotspots, Trends, and Molecular Mechanisms of Diabetes and Sarcopenia: A Bibliometric and Bioinformatics Analysis.

Endocrine, metabolic & immune disorders drug targets·2026

Related Experiment Video

Updated: Jul 5, 2025

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.6K

Self-Assembling E2-Based Nanoparticles Improve Vaccine Thermostability and Protective Immunity against CSFV.

Hetao Song1, Sahibzada Waheed Abdullah2, Chenchen Pei2

  • 1College of Veterinary Medicine, Northwest A&F University, Yangling 712100, China.

International Journal of Molecular Sciences
|January 11, 2024
PubMed
Summary

A novel nanoparticle vaccine using self-assembled mi3 NPs carrying the Classical swine fever virus (CSFV) E2 glycoprotein demonstrated excellent stability and induced strong immune responses in pigs, offering complete protection against CSFV challenge.

Keywords:
CSFVE2nanoparticlesprotective immunitythermostabilityvaccine

More Related Videos

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.6K
Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

6.9K

Related Experiment Videos

Last Updated: Jul 5, 2025

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.6K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.6K
Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

6.9K

Area of Science:

  • Veterinary Virology
  • Nanotechnology in Vaccines
  • Immunology

Background:

  • Classical swine fever virus (CSFV) causes significant economic losses in the swine industry.
  • Current vaccines face biosafety concerns and limitations in distinguishing infected from vaccinated animals.
  • Nanoparticle (NP)-based vaccines offer a promising alternative due to their structural resemblance to natural viruses.

Purpose of the Study:

  • To develop an innovative nanoparticle vaccine delivery system for CSFV.
  • To evaluate the stability, immunogenicity, and protective efficacy of the novel CSFV E2-mi3 NP vaccine.

Main Methods:

  • Development of self-assembled mi3 NPs carrying the CSFV E2 glycoprotein (E2-mi3 NPs).
  • Assessment of E2-mi3 NP thermostability and storage stability.
  • Evaluation of antigen uptake by macrophages (RAW264.7 cells).
  • Immunization of rabbits and pigs, followed by CSFV challenge and immune response analysis.

Main Results:

  • E2-mi3 NPs exhibited robust thermal and long-term storage stability.
  • The vaccine enhanced antigen uptake by immune cells.
  • In rabbits, the E2-mi3 NP vaccine induced high CSFV-specific neutralizing antibody titers and conferred complete protection.
  • In pigs, E2-mi3 NPs triggered stronger cellular and humoral immune responses compared to conventional E2 vaccines.

Conclusions:

  • Self-assembled mi3 NPs serve as an effective scaffold for CSFV vaccines.
  • This novel nanoparticle vaccine strategy shows potential for improved antiviral therapies against CSFV.
  • The findings offer valuable insights for developing next-generation antiviral strategies.